SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Medtronic plc – ‘10-K’ for 4/29/22 – ‘EX-32.2’

On:  Thursday, 6/23/22, at 4:13pm ET   ·   For:  4/29/22   ·   Accession #:  1613103-22-23   ·   File #:  1-36820

Previous ‘10-K’:  ‘10-K’ on 6/25/21 for 4/30/21   ·   Next & Latest:  ‘10-K’ on 6/22/23 for 4/28/23   ·   56 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 6/23/22  Medtronic plc                     10-K        4/29/22  130:25M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.39M 
 2: EX-4.25     Instrument Defining the Rights of Security Holders  HTML    162K 
 3: EX-21       Subsidiaries List                                   HTML     93K 
 4: EX-22       Published Report re: Matters Submitted to a Vote    HTML     35K 
                of Security Holders                                              
 5: EX-23       Consent of Expert or Counsel                        HTML     34K 
 6: EX-24       Power of Attorney                                   HTML     37K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     39K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     35K 
16: R1          Cover                                               HTML    145K 
17: R2          Audit Information                                   HTML     39K 
18: R3          Consolidated Statements of Income                   HTML    121K 
19: R4          Consolidated Statements of Comprehensive Income     HTML     78K 
20: R5          Consolidated Balance Sheets                         HTML    162K 
21: R6          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
22: R7          Consolidated Statements of Equity                   HTML    126K 
23: R8          Consolidated Statements of Equity (Parenthetical)   HTML     36K 
24: R9          Consolidated Statements of Cash Flows               HTML    132K 
25: R10         Summary of Significant Accounting Policies          HTML     79K 
26: R11         Revenue                                             HTML     98K 
27: R12         Acquisitions                                        HTML     67K 
28: R13         Restructuring Charges                               HTML     86K 
29: R14         Financial Instruments                               HTML    174K 
30: R15         Financing Arrangements                              HTML    145K 
31: R16         Derivatives and Currency Exchange Risk Management   HTML    157K 
32: R17         Inventories                                         HTML     42K 
33: R18         Goodwill and Other Intangible Assets                HTML     87K 
34: R19         Property, Plant, and Equipment                      HTML     50K 
35: R20         Shareholders' Equity                                HTML     44K 
36: R21         Stock Purchase and Award Plans                      HTML    121K 
37: R22         Income Taxes                                        HTML    175K 
38: R23         Earnings Per Share                                  HTML     56K 
39: R24         Retirement Benefit Plans                            HTML    300K 
40: R25         Leases                                              HTML     77K 
41: R26         Accumulated Other Comprehensive Loss                HTML     83K 
42: R27         Commitments and Contingencies                       HTML     54K 
43: R28         Segment and Geographic Information                  HTML    117K 
44: R29         Subsequent Events                                   HTML     37K 
45: R30         Schedule II                                         HTML     73K 
46: R31         Summary of Significant Accounting Policies          HTML    139K 
                (Policies)                                                       
47: R32         Revenue (Tables)                                    HTML     90K 
48: R33         Acquisitions (Tables)                               HTML     60K 
49: R34         Restructuring Charges (Tables)                      HTML     74K 
50: R35         Financial Instruments (Tables)                      HTML    180K 
51: R36         Financing Arrangements (Tables)                     HTML    136K 
52: R37         Derivatives and Currency Exchange Risk Management   HTML    186K 
                (Tables)                                                         
53: R38         Inventories (Tables)                                HTML     43K 
54: R39         Goodwill and Other Intangible Assets (Tables)       HTML    108K 
55: R40         Property, Plant, and Equipment (Tables)             HTML     50K 
56: R41         Stock Purchase and Award Plans (Tables)             HTML    124K 
57: R42         Income Taxes (Tables)                               HTML    162K 
58: R43         Earnings Per Share (Tables)                         HTML     54K 
59: R44         Retirement Benefit Plans (Tables)                   HTML    296K 
60: R45         Leases (Tables)                                     HTML     75K 
61: R46         Accumulated Other Comprehensive Loss (Tables)       HTML     78K 
62: R47         Segment and Geographic Information (Tables)         HTML    114K 
63: R48         Summary of Significant Accounting Policies          HTML     52K 
                (Details)                                                        
64: R49         Revenue - Disaggregation of Net Sales by Segment    HTML     66K 
                and Division (Details)                                           
65: R50         Revenue - Disaggregation of Net Sales by Market     HTML     69K 
                Geography for Each Segment (Details)                             
66: R51         Revenue - Narrative (Details)                       HTML     52K 
67: R52         Acquisitions - Additional Information (Details)     HTML     89K 
68: R53         Acquisitions - Contingent Consideration (Details)   HTML     76K 
69: R54         Restructuring Charges - Additional Information      HTML     91K 
                (Details)                                                        
70: R55         Restructuring Charges (Details)                     HTML     63K 
71: R56         Financial Instruments - Investments by Category     HTML    103K 
                and Related Balance Sheet Presentation (Details)                 
72: R57         Financial Instruments - AFS in Continuous Loss      HTML     66K 
                Position (Details)                                               
73: R58         Financial Instruments - Additional Information      HTML     40K 
                (Details)                                                        
74: R59         Financial Instruments - Activity Related to the     HTML     59K 
                Company's Debt Securities Portfolio and                          
                Available-for-sale Debt Securities Contractual                   
                Maturities (Details)                                             
75: R60         Financial Instruments - Summary of Equity and       HTML     44K 
                Other Investments (Details)                                      
76: R61         Financial Instruments - Activity Related to the     HTML     44K 
                Company's Investment Portfolio, Equity and Other                 
                Investments (Details)                                            
77: R62         Financing Arrangements - Current Debt Obligations   HTML     61K 
                (Details)                                                        
78: R63         Financing Arrangements - Additional Information     HTML    151K 
                (Details)                                                        
79: R64         Financing Arrangements - Long-term Debt (Details)   HTML    133K 
80: R65         Financing Arrangements - Long-term Debt Maturities  HTML     54K 
                (Details)                                                        
81: R66         Derivatives and Currency Exchange Risk Management   HTML     79K 
                - Narrative (Details)                                            
82: R67         Derivatives and Currency Exchange Risk Management   HTML     56K 
                - Derivative (Gains) Losses Designated as Hedging                
                Instruments (Details)                                            
83: R68         Derivatives and Currency Exchange Risk Management   HTML     43K 
                - Gains and Losses on Derivatives Not Designated                 
                as Hedging Instruments (Details)                                 
84: R69         Derivatives and Currency Exchange Risk Management   HTML     64K 
                - Classification and Fair Value Amounts of                       
                Derivative Instruments in Balance Sheets (Details)               
85: R70         Derivatives and Currency Exchange Risk Management   HTML     46K 
                - Derivative Assets and Liabilities Measured at                  
                Fair Value on a Recurring Basis (Details)                        
86: R71         Derivatives and Currency Exchange Risk Management   HTML     79K 
                - Offsetting Assets and Liabilities (Details)                    
87: R72         Inventories (Details)                               HTML     44K 
88: R73         Goodwill and Other Intangible Assets - Changes in   HTML     62K 
                Goodwill (Details)                                               
89: R74         Goodwill and Other Intangible Assets - Intangible   HTML     65K 
                Assets (Details)                                                 
90: R75         Goodwill and Other Intangible Assets -              HTML     49K 
                Amortization Expense (Details)                                   
91: R76         Property, Plant, and Equipment (Details)            HTML     67K 
92: R77         Shareholders' Equity (Details)                      HTML     75K 
93: R78         Stock Purchase and Award Plans - Additional         HTML     84K 
                Information (Details)                                            
94: R79         Stock Purchase and Award Plans - Stock-based        HTML     57K 
                Compensation Expense (Details)                                   
95: R80         Stock Purchase and Award Plans - Valuation          HTML     48K 
                Assumptions (Details)                                            
96: R81         Stock Purchase and Award Plans - Stock Options      HTML     92K 
                Activity (Details)                                               
97: R82         Stock Purchase and Award Plans - Restricted Stock   HTML     63K 
                Activity (Details)                                               
98: R83         Stock Purchase and Award Plans - Performance Share  HTML     58K 
                Unit Activity (Details)                                          
99: R84         Income Taxes - Components of Income Before Income   HTML     44K 
                Taxes, Based on Jurisdiction (Details)                           
100: R85         Income Taxes - Income Tax (Benefit) Provision       HTML     57K  
                (Details)                                                        
101: R86         Income Taxes - Schedule of Deferred Tax Assets and  HTML    102K  
                Liabilities (Details)                                            
102: R87         Income Taxes - Additional Information (Details)     HTML    116K  
103: R88         Income Taxes - Effective Income Tax Rate            HTML     70K  
                Reconciliation (Details)                                         
104: R89         Income Taxes - Reconciliation of Beginning and      HTML     56K  
                Ending Amount of Unrecognized Tax Benefits                       
                (Details)                                                        
105: R90         Earnings Per Share (Details)                        HTML     82K  
106: R91         Retirement Benefit Plans - Additional Information   HTML    135K  
                (Details)                                                        
107: R92         Retirement Benefit Plans - Change in Benefit        HTML    151K  
                Obligation and Funded Status (Details)                           
108: R93         Retirement Benefit Plans - Net Periodic Cost and    HTML     87K  
                AOCI (Details)                                                   
109: R94         Retirement Benefit Plans - Actuarial Assumptions    HTML     91K  
                and Plan Assets Target Allocations (Details)                     
110: R95         Retirement Benefit Plans - Fair Value Measurement   HTML    120K  
                (Details)                                                        
111: R96         Retirement Benefit Plans - Future Benefit Payments  HTML     55K  
                (Details)                                                        
112: R97         Leases - Balance Sheet Classification and Amounts   HTML     47K  
                of Right-of-Use Assets and Lease Liabilities                     
                (Details)                                                        
113: R98         Leases - Weighted-Average Remaining Lease Term and  HTML     39K  
                Weighted-Average Discount Rate for Operating                     
                Leases (Details)                                                 
114: R99         Leases - Components of Total Operating Lease Cost   HTML     41K  
                (Details)                                                        
115: R100        Leases - Supplemental Cash Flow Information         HTML     39K  
                (Details)                                                        
116: R101        Leases - Maturities of Operating Leases (Details)   HTML     53K  
117: R102        Accumulated Other Comprehensive Loss (Details)      HTML    103K  
118: R103        Commitments and Contingencies (Details)             HTML     67K  
119: R104        Segment and Geographic Information - Additional     HTML     38K  
                Information (Details)                                            
120: R105        Segment and Geographic Information - Income From    HTML     92K  
                Operations Before Income Taxes by Reportable                     
                Segment and Reconciliation to Consolidated                       
                (Details)                                                        
121: R106        Segment and Geographic Information -                HTML     61K  
                Reconciliation of Assets and Depreciation Expense                
                from Segments to Consolidated (Details)                          
122: R107        Segment and Geographic Information - Schedule of    HTML     54K  
                Net Sales to External Customers and Property,                    
                Plant, and Equipment, Net, by Geographic Region                  
                (Details)                                                        
123: R108        Subsequent Events (Details)                         HTML     44K  
124: R109        Schedule II (Details)                               HTML     54K  
125: R9999       Uncategorized Items - mdt-20220429.htm              HTML     52K  
128: XML         IDEA XML File -- Filing Summary                      XML    248K  
126: XML         XBRL Instance -- mdt-20220429_htm                    XML   6.62M  
127: EXCEL       IDEA Workbook of Financial Reports                  XLSX    221K  
12: EX-101.CAL  XBRL Calculations -- mdt-20220429_cal                XML    398K 
13: EX-101.DEF  XBRL Definitions -- mdt-20220429_def                 XML   1.50M 
14: EX-101.LAB  XBRL Labels -- mdt-20220429_lab                      XML   3.41M 
15: EX-101.PRE  XBRL Presentations -- mdt-20220429_pre               XML   2.10M 
11: EX-101.SCH  XBRL Schema -- mdt-20220429                          XSD    311K 
129: JSON        XBRL Instance as JSON Data -- MetaLinks              785±  1.16M  
130: ZIP         XBRL Zipped Folder -- 0001613103-22-000023-xbrl      Zip   1.85M  


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 32.2
Certification of Chief Financial Officer
Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

In connection with this annual report on Form 10-K of Medtronic plc for the fiscal year ended April 29, 2022, the undersigned hereby certifies, in her capacity as Chief Financial Officer of Medtronic plc, for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Medtronic plc.
June 23, 2022
Executive Vice President and
Chief Financial Officer




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:6/23/22IRANNOTICE
For Period end:4/29/22
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/24/23  Medtronic plc                     424B5                  2:1M                                     Donnelley … Solutions/FA
 3/23/23  Medtronic plc                     424B3                  1:977K                                   Donnelley … Solutions/FA
 3/03/23  Medtronic plc                     S-3ASR      3/03/23   13:1.3M                                   Donnelley … Solutions/FA
 9/16/22  Medtronic plc                     424B5                  2:950K                                   Donnelley … Solutions/FA
 9/15/22  Medtronic plc                     424B3                  1:880K                                   Donnelley … Solutions/FA


51 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/03/22  Medtronic plc                     10-Q        1/28/22   99:15M
12/14/21  Medtronic plc                     8-K:1,5,9  12/09/21   12:651K
12/03/20  Medtronic plc                     10-Q       10/30/20   98:15M
 9/29/20  Medtronic plc                     8-K:1,7,8,9 9/24/20   17:1M                                     Donnelley … Solutions/FA
 6/19/20  Medtronic plc                     10-K        4/24/20  136:30M
 5/13/20  Medtronic plc                     8-K:1,2,7   5/12/20   13:1.1M
 2/28/20  Medtronic plc                     10-Q        1/24/20  110:32M
12/03/19  Medtronic plc                     10-Q       10/25/19  110:30M
 7/02/19  Medtronic plc                     8-K:1,7,8,9 7/02/19    7:672K                                   Donnelley … Solutions/FA
 3/07/19  Medtronic plc                     8-K:1,7,8,9 3/07/19    9:864K                                   Donnelley … Solutions/FA
12/13/18  Medtronic plc                     8-K:1,9    12/12/18    2:622K                                   Donnelley … Solutions/FA
 6/22/18  Medtronic plc                     10-K        4/27/18  136:37M
12/12/17  Medtronic plc                     8-K:5,9    12/08/17    2:312K
 9/01/17  Medtronic plc                     10-Q        7/28/17   92:21M
 3/28/17  Medtronic plc                     8-K:1,9     3/28/17    8:785K                                   Donnelley … Solutions/FA
 2/06/17  Medtronic plc                     S-3ASR      2/06/17   13:2.3M                                   Donnelley … Solutions/FA
12/05/16  Medtronic plc                     10-Q       10/28/16   89:25M
 5/04/16  Medtronic plc                     8-K:5,9     5/02/16    3:83K                                    Donnelley … Solutions/FA
 6/23/15  Medtronic plc                     10-K        4/24/15  115:33M
 2/27/15  Medtronic plc                     10-Q        1/23/15   42:2M
 1/28/15  Medtronic plc                     S-8         1/28/15    7:1.1M                                   Donnelley … Solutions/FA
 1/27/15  Medtronic plc                     8-K:5,8,9   1/22/15   17:1.2M                                   Donnelley … Solutions/FA
 1/27/15  Medtronic plc                     8-K12B:1,2, 1/23/15   11:852K                                   Donnelley … Solutions/FA
 1/27/15  Medtronic plc                     8-K:5,8,9   1/22/15   17:1.2M                                   Donnelley … Solutions/FA
 1/27/15  Medtronic plc                     8-K:1,2,3,5 1/23/15   11:859K                                   Donnelley … Solutions/FA
12/10/14  Medtronic Inc.                    8-K:1,2,9  12/10/14    4:1M                                     Donnelley … Solutions/FA
 8/29/14  Medtronic Inc.                    10-Q        7/25/14   90:14M
 6/20/14  Medtronic Inc.                    10-K        4/25/14  111:33M
 2/27/14  Medtronic Inc.                    8-K:8,9     2/27/14    5:425K                                   Donnelley … Solutions/FA
 8/27/13  Medtronic Inc.                    8-K:5,9     8/22/13    9:403K                                   Donnelley … Solutions/FA
 5/16/13  Covidien plc                      8-K:1,8,9   5/13/13    7:444K                                   Donnelley … Solutions/FA
 3/26/13  Medtronic Inc.                    8-K:8,9     3/26/13    5:326K                                   Donnelley … Solutions/FA
 6/26/12  Medtronic Inc.                    10-K        4/27/12  100:24M                                    American Fin’l P… Inc/FA
 5/30/12  Covidien plc                      8-K:1,8,9   5/22/12    8:518K                                   Donnelley … Solutions/FA
 3/20/12  Medtronic Inc.                    8-K:8,9     3/14/12    5:279K                                   Donnelley … Solutions/FA
 3/16/11  Medtronic Inc.                    8-K:8,9     3/10/11    4:249K                                   Donnelley … Solutions/FA
 6/28/10  Covidien plc                      8-K:1,8,9   6/21/10    9:634K                                   Donnelley … Solutions/FA
 3/16/10  Medtronic Inc.                    8-K:8,9     3/11/10    4:234K                                   Donnelley … Solutions/FA
12/09/09  Medtronic Inc.                    10-Q       10/30/09   14:2.1M                                   American Fin’l P… Inc/FA
 6/05/09  Covidien plc                      8-K12G3:1,2 6/04/09   10:1.4M                                   Donnelley … Solutions/FA
 3/12/09  Medtronic Inc.                    8-K:8,9     3/09/09    4:211K                                   Bowne Boc/FA
 3/09/09  Medtronic Inc.                    S-3ASR      3/09/09    7:635K                                   Bowne Boc/FA
12/03/08  Medtronic Inc.                    10-Q       10/24/08    9:932K                                   American Fin’l P… Inc/FA
 9/03/08  Medtronic Inc.                    10-Q        7/25/08   12:1.1M                                   American Fin’l P… Inc/FA
 6/24/08  Medtronic Inc.                    10-K        4/25/08   17:2.8M                                   American Fin’l P… Inc/FA
 3/04/08  Medtronic Inc.                    10-Q        1/25/08   13:1.6M                                   American Fin’l P… Inc/FA
12/04/07  Medtronic Inc.                    10-Q       10/26/07   10:1.5M                                   American Fin’l P… Inc/FA
10/22/07  Covidien plc                      8-K:1,2,9  10/17/07    7:1M                                     Donnelley … Solutions/FA
 6/28/06  Medtronic Inc.                    10-K        4/28/06   19:2.5M                                   American Fin’l P… Inc/FA
 6/29/05  Medtronic Inc.                    10-K        4/29/05   16:1.4M                                   American Fin’l P… Inc/FA
 3/07/05  Medtronic Inc.                    10-Q        1/28/05   10:1.9M                                   Toppan Merrill/FA
Top
Filing Submission 0001613103-22-000023   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 9:08:57.4am ET